Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ferrosoferric Oxide | 6 | 2021 | 358 | 1.340 |
Why?
|
| Androstadienes | 8 | 2009 | 345 | 0.970 |
Why?
|
| Nanoparticles | 6 | 2022 | 1898 | 0.840 |
Why?
|
| Radioisotopes | 3 | 2020 | 500 | 0.710 |
Why?
|
| Isotope Labeling | 1 | 2020 | 405 | 0.630 |
Why?
|
| Androstenes | 5 | 2009 | 168 | 0.620 |
Why?
|
| Nanostructures | 4 | 2017 | 552 | 0.610 |
Why?
|
| Fluorescent Dyes | 10 | 2022 | 1903 | 0.590 |
Why?
|
| Hot Temperature | 3 | 2018 | 1351 | 0.570 |
Why?
|
| Click Chemistry | 1 | 2017 | 94 | 0.560 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 4 | 2018 | 1108 | 0.490 |
Why?
|
| Magnetite Nanoparticles | 3 | 2020 | 321 | 0.410 |
Why?
|
| Positron-Emission Tomography | 7 | 2020 | 6237 | 0.390 |
Why?
|
| Radiopharmaceuticals | 5 | 2020 | 2647 | 0.330 |
Why?
|
| Bacteriocins | 4 | 2009 | 87 | 0.330 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 277 | 0.320 |
Why?
|
| Prodrugs | 4 | 2009 | 263 | 0.290 |
Why?
|
| Caproates | 1 | 2006 | 18 | 0.280 |
Why?
|
| Glucosides | 1 | 2009 | 451 | 0.260 |
Why?
|
| Molecular Structure | 8 | 2017 | 1894 | 0.250 |
Why?
|
| Chelating Agents | 2 | 2020 | 379 | 0.250 |
Why?
|
| Polyethylene Glycols | 5 | 2017 | 1181 | 0.220 |
Why?
|
| Receptors, CXCR4 | 3 | 2013 | 727 | 0.220 |
Why?
|
| Chromatography, Gel | 2 | 2020 | 670 | 0.210 |
Why?
|
| Succinimides | 1 | 2021 | 79 | 0.200 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 97 | 0.200 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2021 | 204 | 0.190 |
Why?
|
| Peptides | 5 | 2013 | 4406 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2009 | 2938 | 0.180 |
Why?
|
| Lutetium | 1 | 2020 | 32 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2009 | 1938 | 0.170 |
Why?
|
| Copper Radioisotopes | 1 | 2020 | 88 | 0.170 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2013 | 520 | 0.170 |
Why?
|
| Zirconium | 2 | 2020 | 100 | 0.170 |
Why?
|
| Drug Design | 3 | 2009 | 1075 | 0.160 |
Why?
|
| Iron Radioisotopes | 1 | 2018 | 21 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3794 | 0.160 |
Why?
|
| Fluorescence | 2 | 2018 | 752 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 1789 | 0.150 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2022 | 717 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2017 | 209 | 0.140 |
Why?
|
| Integrins | 2 | 2017 | 846 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 875 | 0.130 |
Why?
|
| Annexin A5 | 1 | 2015 | 103 | 0.130 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5973 | 0.130 |
Why?
|
| Deferoxamine | 1 | 2015 | 151 | 0.120 |
Why?
|
| Nucleic Acids | 1 | 2017 | 182 | 0.120 |
Why?
|
| Autophagy | 1 | 2022 | 1296 | 0.120 |
Why?
|
| Iron Chelating Agents | 1 | 2015 | 139 | 0.120 |
Why?
|
| Light | 2 | 2017 | 1365 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 35409 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 476 | 0.110 |
Why?
|
| Photosensitizing Agents | 1 | 2017 | 602 | 0.110 |
Why?
|
| Chromatography, Thin Layer | 2 | 2020 | 223 | 0.110 |
Why?
|
| Indium Radioisotopes | 1 | 2012 | 118 | 0.110 |
Why?
|
| Carbocyanines | 3 | 2022 | 173 | 0.100 |
Why?
|
| Nanomedicine | 1 | 2015 | 302 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2009 | 461 | 0.100 |
Why?
|
| Dendrimers | 1 | 2011 | 68 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2012 | 111 | 0.100 |
Why?
|
| Photochemotherapy | 1 | 2017 | 808 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1115 | 0.100 |
Why?
|
| Pentetic Acid | 1 | 2011 | 213 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 405 | 0.100 |
Why?
|
| Molecular Probes | 1 | 2012 | 315 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2015 | 690 | 0.090 |
Why?
|
| DNA | 3 | 2013 | 7295 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1518 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 5532 | 0.090 |
Why?
|
| Molecular Conformation | 2 | 2011 | 561 | 0.090 |
Why?
|
| Cytostatic Agents | 1 | 2009 | 8 | 0.090 |
Why?
|
| Animals | 21 | 2022 | 168660 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3758 | 0.090 |
Why?
|
| Cell Line, Tumor | 10 | 2017 | 16674 | 0.090 |
Why?
|
| Magnetics | 1 | 2012 | 604 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2017 | 1066 | 0.080 |
Why?
|
| Tissue Distribution | 4 | 2015 | 2327 | 0.080 |
Why?
|
| Mice | 18 | 2022 | 81154 | 0.080 |
Why?
|
| Esters | 1 | 2009 | 210 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 665 | 0.080 |
Why?
|
| Fluorescein | 2 | 2006 | 171 | 0.080 |
Why?
|
| Tomography, Optical | 1 | 2008 | 125 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 836 | 0.080 |
Why?
|
| Amines | 1 | 2009 | 276 | 0.080 |
Why?
|
| Tetraethylammonium | 1 | 2007 | 58 | 0.080 |
Why?
|
| Mycotoxins | 1 | 2007 | 36 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 291 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2009 | 626 | 0.070 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2008 | 273 | 0.070 |
Why?
|
| Drug Stability | 1 | 2007 | 291 | 0.070 |
Why?
|
| Wound Healing | 1 | 2017 | 2776 | 0.070 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2007 | 250 | 0.070 |
Why?
|
| Monocytes | 1 | 2015 | 2593 | 0.070 |
Why?
|
| Solvents | 1 | 2007 | 302 | 0.070 |
Why?
|
| Antineoplastic Agents | 4 | 2017 | 13691 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2015 | 3680 | 0.070 |
Why?
|
| Glycine | 1 | 2009 | 670 | 0.070 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2013 | 948 | 0.060 |
Why?
|
| Molecular Imaging | 3 | 2021 | 821 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4665 | 0.060 |
Why?
|
| Skin | 1 | 2017 | 4372 | 0.060 |
Why?
|
| Microscopy, Confocal | 3 | 2017 | 1962 | 0.060 |
Why?
|
| Bronchoscopy | 1 | 2008 | 861 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6170 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 1631 | 0.050 |
Why?
|
| Intracellular Space | 2 | 2017 | 210 | 0.050 |
Why?
|
| Dimerization | 2 | 2015 | 894 | 0.050 |
Why?
|
| Organic Chemicals | 2 | 2013 | 210 | 0.050 |
Why?
|
| Cell Survival | 3 | 2017 | 5881 | 0.050 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 3503 | 0.050 |
Why?
|
| Cathepsins | 1 | 2022 | 238 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2008 | 1950 | 0.050 |
Why?
|
| Macrolides | 1 | 2022 | 201 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2009 | 10477 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3264 | 0.050 |
Why?
|
| Amino Acids | 1 | 2007 | 1733 | 0.050 |
Why?
|
| Particle Size | 2 | 2015 | 1639 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2009 | 4152 | 0.040 |
Why?
|
| Kinetics | 1 | 2007 | 6476 | 0.040 |
Why?
|
| Necrosis | 2 | 2015 | 1642 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 943 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 567 | 0.040 |
Why?
|
| Thiazines | 1 | 2017 | 38 | 0.040 |
Why?
|
| Inflammation | 2 | 2015 | 10629 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 2134 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4459 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2012 | 6380 | 0.040 |
Why?
|
| Neutrophils | 1 | 2009 | 3718 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 2865 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2017 | 247 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2022 | 2234 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9440 | 0.030 |
Why?
|
| Neoplasms | 2 | 2015 | 21675 | 0.030 |
Why?
|
| Dextrans | 1 | 2017 | 595 | 0.030 |
Why?
|
| Acute Disease | 2 | 2017 | 7150 | 0.030 |
Why?
|
| Humans | 17 | 2021 | 743811 | 0.030 |
Why?
|
| Binding Sites | 2 | 2013 | 6111 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 3547 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 497 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 818 | 0.030 |
Why?
|
| Disulfides | 1 | 2015 | 457 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 2692 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2119 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 738 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2013 | 200 | 0.030 |
Why?
|
| Intercalating Agents | 1 | 2012 | 34 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9272 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2013 | 250 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 729 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 1409 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18027 | 0.030 |
Why?
|
| Quinolines | 1 | 2017 | 732 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 2253 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2020 | 2479 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9377 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1892 | 0.020 |
Why?
|
| Cricetinae | 1 | 2015 | 2475 | 0.020 |
Why?
|
| Diffusion | 1 | 2013 | 831 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 688 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11708 | 0.020 |
Why?
|
| Injections | 1 | 2013 | 839 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2077 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 20121 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2011 | 5445 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1684 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 280 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1545 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 424 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11360 | 0.020 |
Why?
|
| Ear | 1 | 2009 | 172 | 0.020 |
Why?
|
| Peritoneum | 1 | 2009 | 227 | 0.020 |
Why?
|
| Half-Life | 1 | 2009 | 660 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2007 | 93 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 589 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2011 | 595 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 1758 | 0.020 |
Why?
|
| Apoptosis | 2 | 2015 | 9718 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2013 | 708 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5651 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 21824 | 0.020 |
Why?
|
| Contrast Media | 1 | 2020 | 5301 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 2009 | 694 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 2006 | 166 | 0.020 |
Why?
|
| Haptens | 1 | 2006 | 166 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1705 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6750 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 1794 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1862 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 3749 | 0.020 |
Why?
|
| Rats | 2 | 2015 | 24250 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 2378 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 934 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 553 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7172 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 1272 | 0.010 |
Why?
|
| Eosinophils | 1 | 2008 | 954 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1233 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2009 | 1124 | 0.010 |
Why?
|
| Cell Line | 2 | 2009 | 15993 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1374 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3144 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 3128 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9139 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6356 | 0.010 |
Why?
|
| Immunoassay | 1 | 2006 | 751 | 0.010 |
Why?
|
| Immunoconjugates | 1 | 2009 | 901 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4848 | 0.010 |
Why?
|
| Pancreas | 1 | 2006 | 1686 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3281 | 0.010 |
Why?
|
| Colon | 1 | 2006 | 1772 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14714 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12954 | 0.010 |
Why?
|
| Male | 3 | 2021 | 349776 | 0.010 |
Why?
|
| Time Factors | 2 | 2008 | 40038 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19894 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14563 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13809 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12066 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6773 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18107 | 0.010 |
Why?
|
| Female | 3 | 2015 | 380020 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 7479 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 63042 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 9858 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 26345 | 0.000 |
Why?
|
Concepts
(227)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_